| Year |
Citation |
Score |
| 2024 |
Kouamou V, Washaya T, Mapangisana T, Ndhlovu CE, Manasa J. Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe. Aids (London, England). PMID 38227596 DOI: 10.1097/QAD.0000000000003830 |
0.799 |
|
| 2023 |
Kouamou V, Washaya T, Ndhlovu CE, Manasa J. Low Prevalence of Pre-Treatment and Acquired Drug Resistance to Dolutegravir among Treatment Naïve Individuals Initiating on Tenofovir, Lamivudine and Dolutegravir in Zimbabwe. Viruses. 15. PMID 37766288 DOI: 10.3390/v15091882 |
0.825 |
|
| 2023 |
Washaya T, Manasa J, Kouamou V. HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings. Aids (London, England). 37: 1629-1631. PMID 37450629 DOI: 10.1097/QAD.0000000000003600 |
0.805 |
|
| 2023 |
Kouamou V, Machekano R, Mapangisana T, Maposhere C, Mutetwa R, Manasa J, Shamu T, McCarty K, Munyati S, Mutsvangwa J, Bogoshi M, Israelski D, Katzenstein D. Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trial. Plos One. 18: e0281279. PMID 36787296 DOI: 10.1371/journal.pone.0281279 |
0.796 |
|
| 2022 |
Kouamou V, Machekano R, Mapangisana T, Maposhere C, Munyati S, Mutsvangwa J, Shamu T, McCarty K, Katzenstein D, Manasa J. Tenofovir, Lamivudine and Dolutegravir (TLD) among Rural Adolescents in Zimbabwe, a Cautionary Tale. Aids Research and Human Retroviruses. PMID 35959737 DOI: 10.1089/AID.2021.0140 |
0.806 |
|
| 2022 |
Kouamou V, Manasa J, Katzenstein D, McGregor AM, Ndhlovu CE, Makadzange T. Correction for Kouamou et al., "Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income Countries". Journal of Clinical Microbiology. e0070822. PMID 35695562 DOI: 10.1128/jcm.00708-22 |
0.818 |
|
| 2022 |
Kouamou V, Inzaule S, Manasa J. Weight gain stopping/switch rules for antiretroviral clinical trials. Aids (London, England). 36: 1053-1054. PMID 35652678 DOI: 10.1097/QAD.0000000000003221 |
0.677 |
|
| 2021 |
Kouamou V, Ndhlovu CE, Katzenstein D, Manasa J. Rapid HIV-1 drug resistance testing in a resource limited setting: the Pan Degenerate Amplification and Adaptation assay (PANDAA). The Pan African Medical Journal. 40: 57. PMID 34795836 DOI: 10.11604/pamj.2021.40.57.28558 |
0.851 |
|
| 2021 |
Kouamou V, Inzaule S, Manasa J. Dolutegravir drug-resistance monitoring in Africa. The Lancet. Hiv. 8: e664-e666. PMID 34735801 DOI: 10.1016/S2352-3018(21)00268-X |
0.788 |
|
| 2021 |
Madyadi A, Dhoro M, Shamu T, Washaya T, Kouamou V, Chimukangara B, Katzenstein D, Manasa J. HIV-1 genetic diversity and natural polymorphisms of the integrase gene in integrase inhibitor naive patients in Harare, Zimbabwe. Aids Research and Human Retroviruses. PMID 34714124 DOI: 10.1089/AID.2021.0084 |
0.683 |
|
| 2021 |
Kouamou V, Matarise R, Santos ED, Elose N, Manasa J. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity. The Pan African Medical Journal. 39: 255. PMID 34707756 DOI: 10.11604/pamj.2021.39.255.30331 |
0.658 |
|
| 2021 |
Manyana S, Gounder L, Pillay M, Manasa J, Naidoo K, Chimukangara B. HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies. Viruses. 13. PMID 34208165 DOI: 10.3390/v13061125 |
0.421 |
|
| 2021 |
Mapangisana T, Machekano R, Kouamou V, Maposhere C, McCarty K, Mudzana M, Munyati S, Mutsvangwa J, Manasa J, Shamu T, Bogoshi M, Israelski D, Katzenstein D. Viral load care of HIV-1 infected children and adolescents: A longitudinal study in rural Zimbabwe. Plos One. 16: e0245085. PMID 33444325 DOI: 10.1371/journal.pone.0245085 |
0.793 |
|
| 2021 |
Kouamou V, Mavetera J, Manasa J, Ndhlovu CE, Katzenstein D, McGregor AM. Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens? Aids Research and Human Retroviruses. 37: 776-783. PMID 33430681 DOI: 10.1089/AID.2020.0242 |
0.834 |
|
| 2020 |
Kouamou V, Manasa J, Katzenstein D, McGregor AM, Ndhlovu CE, Makadzange T. Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income Countries. Journal of Clinical Microbiology. 58. PMID 32522826 DOI: 10.1128/JCM.01045-20 |
0.814 |
|
| 2020 |
Kouamou V, Varyani B, Shamu T, Mapangisana T, Chimbetete C, Mudzviti T, Manasa J, Kazenstein D. Drug Resistance among Adolescents and Young Adults with Virologic Failure of First Line ART and Response to Second Line Treatment. Aids Research and Human Retroviruses. PMID 32138527 DOI: 10.1089/AID.2019.0232 |
0.84 |
|
| 2020 |
Kouamou V, Manasa J, Katzenstein D, McGregor AM, Ndhlovu CE, Makadzange AT. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy. Aids (London, England). 33: 1729-1737. PMID 31361272 DOI: 10.1097/QAD.0000000000002284 |
0.823 |
|
| 2019 |
Clutter DS, Mazarei G, Sinha R, Manasa J, Nouhin J, LaPrade E, Bolouki S, Tzou PL, Hannita-Hui J, Sahoo MK, Kuimelis P, Kuimelis RG, Pinsky BA, Schoolnik GK, Hassibi A, et al. Multiplex Solid-Phase Melt Curve Analysis for the Point-of-Care Detection of HIV-1 Drug Resistance. The Journal of Molecular Diagnostics : Jmd. PMID 31026601 DOI: 10.1016/J.Jmoldx.2019.02.005 |
0.749 |
|
| 2019 |
De La Cruz J, Vardhanbhuti S, Sahoo MK, Rovner R, Bosch RJ, Manasa J, Katzenstein DA, Pinsky BA. Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens. Open Forum Infectious Diseases. 6: ofz034. PMID 30863788 DOI: 10.1093/Ofid/Ofz034 |
0.76 |
|
| 2019 |
Fitzpatrick MB, Dube Mandishora RS, Katzenstein DA, McCarty K, Weber J, Sahoo MK, Manasa J, Chirenje ZM, Pinsky BA. hrHPV Prevalence and Type Distribution in Rural Zimbabwe: A Community-Based Self-Collection Study using Near-Point-of-Care GeneXpert HPV testing. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 30807869 DOI: 10.1016/J.Ijid.2019.02.022 |
0.583 |
|
| 2018 |
Chimukangara B, Kharsany AB, Lessells RJ, Naidoo K, Rhee SY, Manasa J, Gräf T, Lewis L, Cawood C, Khanyile D, Diallo K, Ayalew KA, Shafer R, Hunt G, Pillay D, et al. Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa. Aids Research and Human Retroviruses. PMID 30430843 DOI: 10.1089/AID.2018.0202 |
0.703 |
|
| 2018 |
Tzou PL, Rhee SY, Pond SLK, Manasa J, Shafer RW. Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy. Scientific Data. 5: 180147. PMID 30040081 DOI: 10.1038/sdata.2018.147 |
0.594 |
|
| 2017 |
Manasa J, Varghese V, Pond SLK, Rhee SY, Tzou PL, Fessel WJ, Jang KS, White E, Rögnvaldsson T, Katzenstein DA, Shafer RW. Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors. Scientific Reports. 7: 11559. PMID 28912582 DOI: 10.1038/s41598-017-11893-8 |
0.662 |
|
| 2017 |
Chimukangara B, Manasa J, Mitchell R, Nyabadza G, Katzenstein D, Masimirembwa C. Community Based Antiretroviral Treatment in Rural Zimbabwe. Aids Research and Human Retroviruses. PMID 28899102 DOI: 10.1089/AID.2017.0029 |
0.652 |
|
| 2017 |
Ratmann O, Wymant C, Colijn C, Danaviah S, Essex M, Frost SDW, Gall A, Gaiseitsiwe S, Grabowski M, Gray R, Guindon S, von Haeseler A, Kaleebu P, Kendall M, Kozlov A, ... Manasa J, et al. HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences. Aids Research and Human Retroviruses. PMID 28540766 DOI: 10.1089/Aid.2017.0061 |
0.348 |
|
| 2016 |
Chimukangara B, Varyani B, Shamu T, Mutsvangwa J, Manasa J, White E, Chimbetete C, Luethy R, Katzenstein D. HIV drug resistance testing among patients failing second line antiretroviral therapy-Comparison of in-house and commercial sequencing. Journal of Virological Methods. PMID 27894862 DOI: 10.1016/j.jviromet.2016.11.010 |
0.827 |
|
| 2016 |
Rossouw TM, Nieuwoudt M, Manasa J, Malherbe G, Lessells RJ, Pillay S, Danaviah S, Mahasha P, van Dyk G, de Oliveira T. HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa. Hiv Medicine. PMID 27353262 DOI: 10.1111/hiv.12400 |
0.55 |
|
| 2016 |
Manasa J, Danaviah S, Lessells RJ, Elshareef M, Tanser F, Wilkinson E, Pillay S, Mthiyane H, Mwambi H, Pillay D, de Oliveira T. Increasing HIV-1 drug resistance between 2010 and 2012 in adults participating in population-based HIV surveillance in rural KwaZulu-Natal South Africa. Aids Research and Human Retroviruses. PMID 27002368 DOI: 10.1089/AID.2015.0225 |
0.583 |
|
| 2016 |
Manasa J, Katzenstein D. Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 519-20. PMID 26561533 DOI: 10.1093/cid/civ931 |
0.539 |
|
| 2014 |
Manasa J, Danaviah S, Pillay S, Padayachee P, Mthiyane H, Mkhize C, Lessells RJ, Seebregts C, de Wit TF, Viljoen J, Katzenstein D, De Oliveira T. An affordable HIV-1 drug resistance monitoring method for resource limited settings. Journal of Visualized Experiments : Jove. PMID 24747156 DOI: 10.3791/51242 |
0.743 |
|
| 2014 |
Lessells RJ, Stott KE, Manasa J, Naidu KK, Skingsley A, Rossouw T, De Oliveira T. Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: Early experiences, achievements and challenges Bmc Health Services Research. 14. PMID 24606875 DOI: 10.1186/1472-6963-14-116 |
0.512 |
|
| 2014 |
Manasa J, Lessells R, Rossouw T, Naidu K, Van Vuuren C, Goedhals D, van Zyl G, Bester A, Skingsley A, Stott K, Danaviah S, Chetty T, Singh L, Moodley P, Iwuji C, et al. Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa. Database : the Journal of Biological Databases and Curation. 2014: bat082. PMID 24504151 DOI: 10.1093/database/bat082 |
0.529 |
|
| 2014 |
Pillay S, Bland RM, Lessells RJ, Manasa J, de Oliveira T, Danaviah S. Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. Aids Research and Therapy. 11: 3. PMID 24444369 DOI: 10.1186/1742-6405-11-3 |
0.54 |
|
| 2013 |
Manasa J, Lessells RJ, Skingsley A, Naidu KK, Newell ML, McGrath N, de Oliveira T. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. Plos One. 8: e72152. PMID 23991055 DOI: 10.1371/journal.pone.0072152 |
0.556 |
|
| 2013 |
Singh L, Parboosing R, Manasa J, Moodley P, de Oliveira T. High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalence. Journal of Medical Virology. 85: 2065-71. PMID 23959597 DOI: 10.1002/jmv.23716 |
0.384 |
|
| 2012 |
Manasa J, Katzenstein D, Cassol S, Newell ML, de Oliveira T. Primary drug resistance in South Africa: data from 10 years of surveys. Aids Research and Human Retroviruses. 28: 558-65. PMID 22251009 DOI: 10.1089/aid.2011.0284 |
0.713 |
|
| 2011 |
Tshabalala M, Manasa J, Zijenah LS, Rusakaniko S, Kadzirange G, Mucheche M, Kassaye S, Johnston E, Katzenstein D. Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. Plos One. 6: e21241. PMID 21698125 DOI: 10.1371/journal.pone.0021241 |
0.813 |
|
| 2009 |
Dalai SC, de Oliveira T, Harkins GW, Kassaye SG, Lint J, Manasa J, Johnston E, Katzenstein D. Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. Aids (London, England). 23: 2523-32. PMID 19770693 DOI: 10.1097/QAD.0b013e3283320ef3 |
0.607 |
|
| Show low-probability matches. |